Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?
Meier
Juris J
JJ
Department of Medicine I, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany. juris.meier@rub.de
Nauck
Michael A
MA
D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000473:pathology*; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism / Q000502:physiology; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism / Q000502:physiology; D006801:Humans; D054795:Incretins / Q000378:metabolism*; D050417:Insulin-Secreting Cells / Q000378:metabolism* / Q000473:pathology*; D008954:Models, Biological
D054795:Incretins; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1